Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Hutchmed (HCM) Share News

78910111213141516

Hutchison China Meditech Starts Phase I Study For Leukemia In China

18th Oct 2018 10:09

LONDON (Alliance News) - Hutchison China Meditech Ltd said Thursday it commenced a phase I study of HMPL-523 to treat elderly patients with acute myeloid leukemia in China.The aim of the is Read More

Hutchison Gains Fruquintinib Capsules Approval As Cancer Drug In China

5th Sep 2018 08:28

LONDON (Alliance News) - Hutchison China Meditech Ltd said Wednesday it gained Chinese approval for its Fruquintinib capsules to be used as treatment for metastatic colorectal cancer.The of Read More

Hutchinson China Meditech Swings To Net Loss, Ups Annual Loss Estimate

27th Jul 2018 08:54

LONDON (Alliance News) - Hutchison China Meditech Ltd on Friday raised its annual loss estimate by USD20 million after swinging to an interim net loss.For the six months to June 30, the a a Read More

UK Earnings, Trading Statements Calendar - Next 7 Days

20th Jul 2018 15:50

Monday 23 July Ryanair HoldingsQ1 ResultsAscentialHalf Year Retail GroupHalf 24 Read More

Hutchison China Cancer Trial Shows Clinically Meaningful Benefits

4th Jun 2018 11:11

LONDON (Alliance News) - Biopharmaceutical company Hutchison China MediTech Ltd said Monday patients in its FRESCO Phase III study "demonstrated a statistically significant and clinically at Read More

UK Shareholder Meetings Calendar - Next 7 Days

20th Apr 2018 15:00

Monday 23 AprilForeign & Colonial Investment Trust BioquellMicrogenHgCapital Read More

Hutchison China Meditech 2017 Loss Widens Amid Rising Research Costs

12th Mar 2018 08:53

LONDON (Alliance News) - China-focused drug developer and distributor Hutchison China Meditech PLC said Monday annual losses widened due to increased and Read More

Hutchison China Meditech Begins New Study For Epitinib Treatment

6th Mar 2018 09:44

LONDON (Alliance News) - Pharmaceutical firm Hutchison China Meditech Ltd has started a phase Ib/II proof-of-concept study for its proposed brain cancer treatment is being in Read More

Hutchinson China Begins In-Human Trial Of Novel Inhibitor HMPL-453

14th Feb 2017 07:47

Read More

Hutchison China Starts Phase One HMPL-523 Trials In China

10th Jan 2017 08:26

Read More

DIRECTOR DEALINGS SUMMARY: Hutchison China Chair Buys US-Listed ADSs

14th Dec 2016 17:13

Read More

DIRECTOR DEALINGS: Hutchison China Chairman Buys US-Listed ADSs

14th Dec 2016 07:51

Read More

DIRECTOR DEALINGS: Hutchison China Non-Executive Sells 10,000 Shares

23rd Nov 2016 11:54

Read More

BROKER RATINGS SUMMARY: Exane BNP And Bernstein Upgrade Morrisons

16th Sep 2016 08:27

Read More

Hutchison China Expands Savolitinib Trials, Gets AstraZeneca Payment

20th Jun 2016 06:41

Read More

Hutchison China MediTech Completes Fruquintinib Trial Enrolment

13th May 2016 06:35

Read More

AGM, EGM Calendar - Week Ahead

20th Apr 2016 15:17

Read More

Hutchison China MediTech Raises USD110.2 Million From Listing (ALLISS)

13th Apr 2016 16:09

Read More

Hutchison China MediTech Starts First In Human Trial Of HMPL-689

12th Apr 2016 06:46

Read More

DIRECTOR DEALINGS: Hutchison China Meditech CEO Buys 36,600 ADSs

29th Mar 2016 10:35

Read More

78910111213141516
FTSE 100 Latest
Value10,223.54
Change51.78